These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9699191)

  • 21. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife.
    Bosworth HB; Bastian LA; Kuchibhatla MN; Steffens DC; McBride CM; Skinner CS; Rimer BK; Siegler IC
    Psychosom Med; 2001; 63(4):603-8. PubMed ID: 11485114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.
    Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS
    J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Climacteric symptoms and hormones.
    Schindler AE
    Gynecol Endocrinol; 2006 Mar; 22(3):151-4. PubMed ID: 16835077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menopausal depression: comparison of hormone replacement therapy and hormone replacement therapy plus fluoxetine.
    Liu P; He FF; Bai WP; Yu Q; Shi W; Wu YY; He DJ; Xiao JH; Zheng Y; Liao QP
    Chin Med J (Engl); 2004 Feb; 117(2):189-94. PubMed ID: 14975200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the quality of life of women in the climacteric period].
    Skrzypulec V; Drosdzol A; Ferensowicz J
    Ginekol Pol; 2004 May; 75(5):373-81. PubMed ID: 15524411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination of hormone replacement therapy with buspirone in the treatment of climacteric complaints].
    Szántó F
    Orv Hetil; 2000 Apr; 141(16):835-7. PubMed ID: 10817010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
    Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
    J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
    Perrone G; Capri O; Borrello M; Galoppi P
    Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When does estrogen replacement therapy improve sleep quality?
    Polo-Kantola P; Erkkola R; Helenius H; Irjala K; Polo O
    Am J Obstet Gynecol; 1998 May; 178(5):1002-9. PubMed ID: 9609575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy and previous use of oral contraceptives among Swedish women.
    Hammar M; Brynhildsen J; Dabrosin L; Frisk J; Lindgren R; Nedstrand E; Wyon Y
    Maturitas; 1996 Nov; 25(3):193-9. PubMed ID: 8981336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Womens attitudes and knowledge about the climacteric period and its treatment. A Swedish population-based study.
    Stadberg E; Mattsson LA; Milsom I
    Maturitas; 1997 Jun; 27(2):109-16. PubMed ID: 9255745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years.
    Groeneveld FP; Bareman FP; Barentsen R; Dokter HJ; Drogendijk AC; Hoes AW
    Maturitas; 1994 Dec; 20(2-3):81-9. PubMed ID: 7715478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin viscoelasticity during hormone replacement therapy for climacteric ageing.
    Piérard GE; Hermanns-Lê T; Paquet P; Piérard-Franchimont C
    Int J Cosmet Sci; 2014 Feb; 36(1):88-92. PubMed ID: 24152248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-adjusted postmenopausal hormone replacement therapy: effects on the biological and immunological profile of FSH and correlation to climacteric symptoms.
    Vihtamaki T; Simoni M; Tuimala R; Nieschlag E; Vihko KK
    Eur J Endocrinol; 2002 Mar; 146(3):333-8. PubMed ID: 11888839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women.
    Dören M; Schneider HP
    Maturitas; 1996 Oct; 25(2):99-105. PubMed ID: 8905600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spanish post-menopausal women's viewpoints on hormone therapy.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
    Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current perspectives on the benefits of HRT in menopausal women.
    Palacios S
    Maturitas; 1999 Nov; 33 Suppl 1():S1-13. PubMed ID: 10661610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Women's anticipations of hormonal replacement therapy.
    Wardell DW; Engebretson JC
    Maturitas; 1995 Nov; 22(3):177-83. PubMed ID: 8746874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of climacteric symptoms in breast cancer patients: a retrospective study from a medication databank.
    Antoine C; Ameye L; Paesmans M; Rozenberg S
    Maturitas; 2014 Jul; 78(3):228-32. PubMed ID: 24852403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.